| Date Filed | Type | Description |
| 10/05/2023 |
4
| Namouni Fouad (PRESIDENT, R & D) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 3,769 shares
@ $48.06, valued at
$181.1k
|
|
| 09/29/2023 |
4
| Albers Jeffrey W. (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 5,600 shares
@ $48.84, valued at
$273.5k
Sold 12,102 shares
@ $49.93, valued at
$604.3k
Sold 400 shares
@ $50.5, valued at
$20.2k
Sold 6,898 shares
@ $50.17, valued at
$346.1k
Exercised 18,102 options to buy
@ $1.87, valued at
$33.9k
Exercised 6,898 options to buy
@ $1.87, valued at
$12.9k
|
|
| 06/07/2023 |
4
| Carter Percy H. (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 2,307 shares
@ $52.06, valued at
$120.1k
|
|
| 06/07/2023 |
4
| Hewes L. Becker (CHIEF MEDICAL OFFICER) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 1,404 shares
@ $52.05, valued at
$73.1k
|
|
| 03/08/2023 |
4
| Murray Christopher K. (CHIEF TECHNICAL OPERATIONS) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 1,829 shares
@ $45.71, valued at
$83.6k
Sold 46 shares
@ $44.3, valued at
$2k
|
|
| 03/08/2023 |
4
| Rossi Christina (COO) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 2,960 shares
@ $45.72, valued at
$135.3k
Sold 99 shares
@ $44.28, valued at
$4.4k
|
|
| 03/08/2023 |
4
| Namouni Fouad (PRESIDENT, R & D) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 1,885 shares
@ $45.72, valued at
$86.2k
Sold 63 shares
@ $44.36, valued at
$2.8k
|
|
| 03/08/2023 |
4
| Hewes L. Becker (CHIEF MEDICAL OFFICER) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 1,466 shares
@ $45.72, valued at
$67k
Sold 48 shares
@ $44.77, valued at
$2.1k
|
|
| 03/08/2023 |
4
| Lee Philina (CHIEF COMMERCIAL OFFICER) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 1,622 shares
@ $45.72, valued at
$74.2k
Sold 54 shares
@ $44.4, valued at
$2.4k
|
|
| 03/08/2023 |
4
| Durso-Bumpus Debra (CHIEF PEOPLE OFFICER) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 3,084 shares
@ $45.71, valued at
$141k
Sold 74 shares
@ $44.3, valued at
$3.3k
|
|
| 03/08/2023 |
4
| Carter Percy H. (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 736 shares
@ $45.72, valued at
$33.6k
Sold 25 shares
@ $44.78, valued at
$1.1k
|
|
| 03/08/2023 |
4
| Albers Jeffrey W. (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 9,474 shares
@ $45.72, valued at
$433.2k
Sold 319 shares
@ $44.27, valued at
$14.1k
|
|
| 03/08/2023 |
4
| McCain Tracey L (EVP AND CHIEF LEGAL OFFICER) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 3,216 shares
@ $45.72, valued at
$147k
Sold 106 shares
@ $44.41, valued at
$4.7k
|
|
| 03/08/2023 |
4
| Landsittel Michael (CFO) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 2,911 shares
@ $45.72, valued at
$133.1k
Sold 96 shares
@ $44.48, valued at
$4.3k
|
|
| 03/08/2023 |
4
| Hurley Ariel (PRINCIPAL ACCOUNTING OFFICER) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 1,091 shares
@ $45.72, valued at
$49.9k
Sold 35 shares
@ $44.4, valued at
$1.6k
|
|
| 03/08/2023 |
4
| Haviland Kate (CEO) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 6,428 shares
@ $45.72, valued at
$293.9k
Sold 212 shares
@ $44.65, valued at
$9.5k
|
|
| 03/03/2023 |
4
| Lee Philina (CHIEF COMMERCIAL OFFICER) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 12,500 shares
@ $0
Granted 25,000 options to buy
@ $43.15, valued at
$1.1M
|
|
| 03/03/2023 |
4
| Carter Percy H. (CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 12,500 shares
@ $0
Granted 25,000 options to buy
@ $43.15, valued at
$1.1M
|
|
| 03/03/2023 |
4
| Hewes L. Becker (CHIEF MEDICAL OFFICER) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 12,500 shares
@ $0
Granted 25,000 options to buy
@ $43.15, valued at
$1.1M
|
|
| 03/03/2023 |
4
| Landsittel Michael (CFO) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 12,500 shares
@ $0
Granted 25,000 options to buy
@ $43.15, valued at
$1.1M
|
|
| 03/03/2023 |
4
| Durso-Bumpus Debra (CHIEF PEOPLE OFFICER) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 12,500 shares
@ $0
Granted 25,000 options to buy
@ $43.15, valued at
$1.1M
|
|
| 03/03/2023 |
4
| Namouni Fouad (PRESIDENT, R & D) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 15,000 shares
@ $0
Granted 30,000 options to buy
@ $43.15, valued at
$1.3M
|
|
| 03/03/2023 |
4
| Haviland Kate (CEO) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 40,000 shares
@ $0
Granted 80,000 options to buy
@ $43.15, valued at
$3.5M
|
|
| 03/03/2023 |
4
| Rossi Christina (COO) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 15,000 shares
@ $0
Granted 30,000 options to buy
@ $43.15, valued at
$1.3M
|
|
| 03/03/2023 |
4
| Hurley Ariel (PRINCIPAL ACCOUNTING OFFICER) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 5,425 shares
@ $0
Granted 10,850 options to buy
@ $43.15, valued at
$468.2k
|
|
| 03/03/2023 |
4
| McCain Tracey L (EVP AND CHIEF LEGAL OFFICER) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 12,500 shares
@ $0
Granted 25,000 options to buy
@ $43.15, valued at
$1.1M
|
|
| 03/03/2023 |
4
| Murray Christopher K. (CHIEF TECHNICAL OPERATIONS) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 8,750 shares
@ $0
Granted 17,500 options to buy
@ $43.15, valued at
$755.1k
|
|
| 01/09/2023 |
4
| Tsai John (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 3,900 shares
@ $0
Granted 7,950 options to buy
@ $46.87, valued at
$372.6k
|
|
| 01/09/2023 |
3
| Tsai John (Director) has filed a Form 3 on Blueprint Medicines Corp |
| 12/07/2022 |
4
| Albers Jeffrey W. (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 20,000 shares
@ $50.09, valued at
$1M
Exercised 10,000 options to buy
@ $1.87, valued at
$18.7k
Exercised 10,000 options to buy
@ $15.01, valued at
$150.1k
|
|
| 11/07/2022 |
4
| Rossi Christina (COO) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 533 shares
@ $45.24, valued at
$24.1k
|
|
| 11/07/2022 |
4
| Haviland Kate (CEO) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Bought 1,100 shares
@ $43.98, valued at
$48.4k
|
|
| 10/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/26/2022 |
4
| Durso-Bumpus Debra (CHIEF PEOPLE OFFICER) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 5,000 shares
@ $75.11, valued at
$375.6k
Exercised 5,000 options to buy
@ $15.01, valued at
$75.1k
|
|
|